Adding ganitumab to exemestane or fulvestrant does not improve PFS in patients with breast cancer Dec. 13, 2010
Safety and preliminary antitumor activity of CEP-18770 reported in first-in-human study Dec. 13, 2010
MN-100 inhibits growth of MM xenografts and alleviates tumor-associated immune suppression in vivo Dec. 13, 2010